Skip to content

Influence of perioperative electroacupuncture on early and long term cognitive function after hip fracture in elderly patients

Influence of perioperative electroacupuncture on early and long term cognitive function after hip fracture in elderly patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053050
Enrollment
Unknown
Registered
2021-11-10
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative cognitive dysfunction

Interventions

Control Group:no
Electroacupuncture pretreatment group:electroacupuncture pretreatment
Electroacupuncture post-treatment group:electroacupuncture post treatment
Electroacupuncture whole treatment group:electroacupuncture pre- and post- treatment

Sponsors

The Second Affiliated Hospital of Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Hip fracture patients: femoral neck fracture, intertrochanteric fracture, acetabular fracture; 2. Aged >= 65 years; 3. ASA classification I~III; 4. The preoperative MMSE score is > 24 for middle school, > 20 for primary school, > 17 for illiteracy; 5. The patient signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe visual or hearing impairment or inability to communicate with visitors for other reasons; 2. Senile dementia, cerebral hemorrhage, sequelae of stroke, installation of pacemaker and other important organ failure; 3. History of epilepsy, alcoholism, neurological disease and mental illness; 4. Preoperative biochemical tests suggest renal dysfunction (serum creatinine > 177 µmol/L) or active liver disease.

Design outcomes

Primary

MeasureTime frame
blood biochemical indexes;arterial blood gas analysis;Scores on the Mini-Mental State Examination (MMSE);Clock Drawing Test (CDT);inflammatory factor;Serum S-100ß;

Secondary

MeasureTime frame
vital signs;adverse reaction;

Countries

China

Contacts

Public ContactChen Wei

The Second Affiliated Hospital of Zhejiang Chinese Medical University

921854896@qq.com+86 13957139320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026